Share-based Compensation (Tables)

3 Months Ended

Mar. 31, 2025

Share-based Compensation

Schedule of assumptions used in estimating the fair value of stock options

	Three Months Ended
	March 31,
	2025	2024
Expected volatility	—	47% – 50%
Risk-free interest rate	—	4.1% – 4.3%
Expected life (in years)	—	5.27 – 6.25
Expected dividend yield	—	—

ABP Sub Inc. 2019 Incentive Award Plan

Share-based Compensation

Schedule of stock option activity

		Weighted
		Average
	Number of	Exercise
	Shares	Price
Outstanding, January 1, 2025	47,955	$	720.00
Options granted	—		—
Options forfeited	—		—
Outstanding, March 31, 2025	47,955	$	720.00
Exercisable, March 31, 2025	43,819	$	720.00

Summary of restricted stock units activity

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
Outstanding, January 1, 2025	11,398	$	780.48
Granted	—		—
Vested	—		—
Forfeited	—		—
Outstanding, March 31, 2025	11,398	$	780.48

AEON Biopharma Inc 2023 Incentive Award Plan

Share-based Compensation

Schedule of stock option activity

		Weighted
		Average
	Number of	Exercise
	Shares	Price
Outstanding, January 1, 2025	51,016	$	242.14
Options granted	—		—
Options forfeited	—		—
Outstanding, March 31, 2025	51,016	$	242.14
Exercisable, March 31, 2025	18,280	$	78.93

Summary of restricted stock units activity

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
Outstanding, January 1, 2025	14,215	$	60.05
Granted	—		—
Vested	—		—
Forfeited	—		—
Outstanding, March 31, 2025	14,215	$	60.05